Skip to main content

AusPAR: Lucentis

Australian Public Assessment Report
Device/Product Name
Lucentis
Active ingredients
Ranibizumab
AusPAR Date
Published
Submission Number
PM-2020-04187-1-5
Submission Type
Extension of indications
Decision
Approved

Help us improve the Therapeutic Goods Administration site